Quick Answer (for busy buyers)
Here’s the buyer-first summary. If your brand name is on the label, you usually act as the responsible person and must ensure the listing is submitted and kept current.
- For US private label eye care, most brands reach a production-ready formula in 2 sample rounds; 3 rounds is common when you change actives, need a fragrance-free skin feel, or switch packaging (airless pump vs jar).
- Round 1 confirms texture, absorption, and eye-area comfort; round 2 locks the benchmark and your claims boundary.
- Each round runs through formula adjustment, small-batch making, a basic fill check, and your feedback.
- Packaging fit is a frequent trigger for an extra round: higher-viscosity eye creams may not dispense smoothly from small pumps, so we verify fillability and risk points like poor output or leakage before you sign off.
- After the final sample is approved, mass production is typically 10-20 working days, but packaging ordering is often the main gate (10-30 working days).
- As reference, glass bottles and tubes are often about 15 working days, acrylic bottles can be about 30, mono cartons about 15, and set boxes about 20.
- MOQ is usually 1,000-3,000 pcs per SKU, driven by formula/packaging complexity.
- We can support testing coordination and documentation (e.g., ingredient list/INCI, COA, MSDS), but you should confirm US cosmetic vs OTC positioning and claims with your compliance advisor.
Buyer outcome
A launch-ready compliance plan: inputs collected, roles assigned, and update cadence defined.
Most common blocker
Missing facility information + inconsistent ingredient/label snapshots across SKUs.
⚠️
This page is a practical buyer guide. For definitive requirements and updates, use FDA resources and qualified regulatory counsel.
